课题基金 / 基金详情

HIV-1 assembly and release

HIV-1 assembly and release
HIV-1的组装和释放
批准号:
9382562
负责人:
Paul D. Bieniasz
金额:
$21.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-01-01 至 2017-07-19
关键词:

项目摘要

项目成果

Paul D. Bieniasz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The assembly and release of HIV-1 particles is quite complex, in that a number of viral and cellular RNAs and proteins participate, and while much has been learned about this process, much remains to be discovered. The Gag protein is central to the assembly and release of HIV-1 and all other retrovirus particles. A key function of the Gag protein that will be one focus of tis proposal is the recruitment and packaging of viral genomic RNA (gRNA). Reciprocally, gRNA may help to drive the recruitment of additional Gag molecules into a virion as assembly progresses. However, the full extent to which RNA participates in particle assembly in cells, and how Gag:RNA interactions change as assembly is initiated and completed remain to be defined. The experiments proposed in specific aim 1 will be the first to determine precisely how HIV-1 Gag and gRNA interact in cells. These studies could identify the very first as well as subsequent interactions between Gag protein and gRNA as well as between gRNA and antiviral cytidine deaminases. Following assembly, HIV-1 particles depart from the surface of the infected cell, to colonize neighboring or distal uninfected cells. During the previous funding period, we identified an IFN-induced membrane protein, termed tetherin, as a host defense molecule that inhibits HIV-1 particle release. Our work has demonstrated that tetherin acts directly, to retain nascent virions on the cell surface, but key mechanistic details of how tetherin functions, and what role t plays in preventing the dissemination of viral infection in cultured cells and in vivo remain to b determined. In specific aim 2, we will perform a series of in vitro and in vivo experiments to address these key questions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Broad neutralization of pandemic threat coronaviruses
  • 批准号:
    10327989
  • 项目类别:
  • 资助金额:
    $642.33万
  • 财政年份:
    2022
  • 负责人:
    Paul D. Bieniasz
  • 依托单位:
Effects of Interferon on primate lentiviruses
  • 批准号:
    10619797
  • 项目类别:
  • 资助金额:
    $71.01万
  • 财政年份:
    2022
  • 负责人:
    Paul D. Bieniasz
  • 依托单位:
Broad neutralization of pandemic threat coronaviruses
  • 批准号:
    10841237
  • 项目类别:
  • 资助金额:
    $425.9万
  • 财政年份:
    2022
  • 负责人:
    Paul D. Bieniasz
  • 依托单位:
Effects of Interferon on primate lentiviruses
  • 批准号:
    10708965
  • 项目类别:
  • 资助金额:
    $70.56万
  • 财政年份:
    2022
  • 负责人:
    Paul D. Bieniasz
  • 依托单位:
国内基金
海外基金
ENKD1在纺锤体定向中的作用及分子机制
  • 批准号:
    32000490
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    孙爽
  • 依托单位:
果蝇纤毛细胞中特化细胞骨架的结构及其建立的分子基础解析
  • 批准号:
    32070704
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    梁鑫
  • 依托单位:
植物基因重组频率的遗传调控
肌球蛋白18B通过影响微丝应力纤维组装调控肿瘤细胞迁移的机制研究